- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The oral combination antiviral Paxlovid has been conditionally approved (in Chinese) for use. Like many other countries that have approved the medication, it is reserved for use in adults who have mild to moderate illness, but are at high risk of severe disease.
See COVID-19 Treatment for more information on Paxlovid.
Additional data provided by
English
Japanese
